Citadel Advisors’s Actuate Therapeutics, Inc. Common stock ACTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-14,185
Closed -$96K 7261
2025
Q1
$96K Buy
+14,185
New +$96K ﹤0.01% 5168